TRENTON, N.J. (AP) — A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry researchers collaborating and sharing their findings like never before.
(Reuters) – Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs & Co to buy back $5 billion of its stock. Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month. Under the agreement, which forms a part of Pfizer's existing buyback authorization, about 150 million shares will be bought. The settlement is expected during or prior to the third quarter. Shares of the New York-based company closed at $33.06 on the New York Stock Exchange on Monday. …